135 related articles for article (PubMed ID: 3881692)
1. Placebo-controlled study of mesulergine in Parkinson's disease.
Jankovic J; Orman J; Jansson B
Neurology; 1985 Feb; 35(2):161-5. PubMed ID: 3881692
[TBL] [Abstract][Full Text] [Related]
2. Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Rascol A; Montastruc JL; Rascol O; Senard JM
Clin Neuropharmacol; 1986; 9(2):146-52. PubMed ID: 3708600
[TBL] [Abstract][Full Text] [Related]
3. Mesulergine in early Parkinson's disease: a double blind controlled trial.
Dupont E; Mikkelsen B; Jakobsen J
J Neurol Neurosurg Psychiatry; 1986 Apr; 49(4):390-5. PubMed ID: 3517235
[TBL] [Abstract][Full Text] [Related]
4. Mesulergine (CU32-085) in the treatment of Parkinson's disease.
Pfeiffer RF; Wilken K; Glaeske C
Ann Neurol; 1985 Apr; 17(4):334-6. PubMed ID: 3890700
[TBL] [Abstract][Full Text] [Related]
5. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pergolide and mesulergine.
Lieberman AN; Gopinathan G; Neophytides A
Eur Neurol; 1986; 25(2):86-90. PubMed ID: 3948891
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
8. CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's disease.
Rascol O; Fabre N; Teräväinen H; Poewe W; Lücking C; Rinne U; Dupont E; Hirt D; Hoyer M; Lataste X
Clin Neuropharmacol; 1990 Aug; 13(4):303-11. PubMed ID: 2208182
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy.
Jankovic J
Neurology; 1983 Apr; 33(4):505-7. PubMed ID: 6339985
[TBL] [Abstract][Full Text] [Related]
10. Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
Schneider E; Baas H; Fischer PA; Japp G
J Neurol; 1985; 232(1):24-8. PubMed ID: 3998771
[TBL] [Abstract][Full Text] [Related]
11. The use of pergolide, a potent dopamine agonist, in Parkinson's disease.
Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Walker R; Pact V
Clin Pharmacol Ther; 1982 Jul; 32(1):70-5. PubMed ID: 7083733
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
Schneider E; Hubener K; Fischer PA
Adv Neurol; 1984; 40():527-9. PubMed ID: 6695631
[No Abstract] [Full Text] [Related]
13. Effect of the putative dopamine D1 agonist and D2 antagonist FCE 23884 on Parkinson's disease.
Metman LV; Blanchet PJ; de Jong D; Mouradian MM; Chase TN
Mov Disord; 1996 May; 11(3):257-60. PubMed ID: 8723141
[TBL] [Abstract][Full Text] [Related]
14. Management of levodopa failures: the use of dopamine agonists.
Lieberman AN; Gopinathan G; Neophytides A; Goldstein M
Clin Neuropharmacol; 1986; 9 Suppl 2():S9-21. PubMed ID: 3297319
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
Marsden CD
Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of pergolide in Parkinson's disease].
Gonce M; Delwaide PJ
Presse Med; 1985 Jun; 14(26):1409-11. PubMed ID: 3161045
[TBL] [Abstract][Full Text] [Related]
17. Cabergoline : a review of its use in the treatment of Parkinson's disease.
Curran MP; Perry CM
Drugs; 2004; 64(18):2125-41. PubMed ID: 15341508
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Jellinger K
J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
[TBL] [Abstract][Full Text] [Related]
19. Mesulergine and pergolide in previously untreated Parkinson's disease.
Wright A; Lees AJ; Stern GM
J Neurol Neurosurg Psychiatry; 1987 Apr; 50(4):482-4. PubMed ID: 3585362
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced Parkinson disease with pergolide.
Lieberman A; Goldstein M; Leibowitz M; Neophytides A; Kupersmith M; Pact V; Kleinberg D
Neurology; 1981 Jun; 31(6):675-82. PubMed ID: 7195484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
